# Glycomine funding: rounds and investors

> Glycomine has raised $160M across 3 rounds since 2017. Investors include Sanderling Ventures, Novo Holdings A/S and Novo Holdings. Every round with its source.

Source: https://millionrounds.com/company/glycomine (Millionrounds; every figure on the page links to its filing or article)

United States · [Series C startup](https://millionrounds.com/companies)

# Who invested in *Glycomine*

3 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$160M** raised across 3 rounds since 2017, from 3 sources

**$12M** Series A **$33M** Series B **$115M** Series C

- **Latest round:** Series C, $115M Apr 2025
- **Step-up i:** 3.5×
- **Investors:** 8 (1 led)

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2019 2021 2023 2025

**$12M** Series A

**$33M** Series B

**$115M** Series C

- **First round:** Series A, $12M
- **Biggest round:** $115M
- **Usual gap between rounds:** 5.7 years

## The rounds

- **Apr 2025** Series C **$115M** *3 new* [Novo Holdings](https://millionrounds.com/fund/novo-ventures) [Sanofi](https://millionrounds.com/fund/sanofi) [Mission BioCapital](https://millionrounds.com/fund/mission-biocapital) Source recorded
- **Aug 2019** Series B **$33M** *4 new* *1 returning* [Novo Holdings A/S](https://millionrounds.com/fund/novo-holdings-a-s) Lead [Sanderling Ventures](https://millionrounds.com/fund/sanderling-ventures) [Mission Bay Capital](https://millionrounds.com/fund/mission-bay-capital) [Chiesi Ventures](https://millionrounds.com/fund/chiesi-ventures) Asahi Kasei Pharma Corporation Reported by FinSMEs
- **Nov 2017** Series A **$12M** *1 new* [Sanderling Ventures](https://millionrounds.com/fund/sanderling-ventures) Reported by FinSMEs

## Founders and team

From Glycomine's own website: 2 on the team.

- **Arthur Pappas** Director
- **Joshua Grass** Chairperson

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series A** 2017 **Series B** 2019 **Series C** 2025 [Sanderling Ventures](https://millionrounds.com/fund/sanderling-ventures) [Novo Holdings A/S](https://millionrounds.com/fund/novo-holdings-a-s) L [Novo Holdings](https://millionrounds.com/fund/novo-ventures) [Sanofi](https://millionrounds.com/fund/sanofi) [Mission BioCapital](https://millionrounds.com/fund/mission-biocapital) [Mission Bay Capital](https://millionrounds.com/fund/mission-bay-capital) [Chiesi Ventures](https://millionrounds.com/fund/chiesi-ventures) Asahi Kasei Pharma Corporation

## Everyone who backed them

[Sanderling Ventures](https://millionrounds.com/fund/sanderling-ventures) VC firm **2** rounds

[Novo Holdings A/S](https://millionrounds.com/fund/novo-holdings-a-s) Growth equity **1** round, led 1

[Novo Holdings](https://millionrounds.com/fund/novo-ventures) VC firm **1** round

[Sanofi](https://millionrounds.com/fund/sanofi) Investment firm **1** round

[Mission BioCapital](https://millionrounds.com/fund/mission-biocapital) VC firm **1** round

[Mission Bay Capital](https://millionrounds.com/fund/mission-bay-capital) VC firm **1** round

[Chiesi Ventures](https://millionrounds.com/fund/chiesi-ventures) VC firm **1** round

Asahi Kasei Pharma Corporation no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=glycomine).

## Also claim to have backed them

This firm lists Glycomine as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

[For Good Ventures](https://millionrounds.com/fund/for-good-ventures) VC firm Per its own site

## Quick answers about Glycomine

### Who invested in Glycomine?

Glycomine's investors include Sanderling Ventures, Novo Holdings A/S, Novo Holdings, Sanofi and Mission BioCapital, and 3 more on record.

### How much has Glycomine raised?

Glycomine has raised $160M across 3 rounds since 2017.

### When did Glycomine last raise?

Glycomine's most recent round was a Series C of $115M in Apr 2025.

### What was Glycomine's biggest round?

Its most recent round, $115M in Apr 2025, is also its largest on record.

### Who backed Glycomine first?

Glycomine's first round on record, in Nov 2017, was backed by Sanderling Ventures.

### What stage is Glycomine at?

Glycomine's latest named round is a Series C, in Apr 2025.

### Where is Glycomine based?

Glycomine is based in the United States.

### Who led Glycomine's rounds?

Novo Holdings A/S led the Series B in 2019.

## Companies like Glycomine

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
